News | October 31, 2025
Merck’s Capvaxive shows strong momentum amid industry vaccine decline
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
The platform is being introduced to expand access to treatments for people living with chronic conditions
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated
